Canada: Pharma In Brief - Health Canada Ordered To Grant A Natural Health Product License For Smoking Cessation Product

Case: The Winning Combination Inc. v Canada (Minister of Health), 2016 FC 381 (Court File No. T-1381-07) 


Nature of case: Application for judicial review of Health Canada's decision refusing marketing authorization under the Food and Drugs Act, RSC 1985, c F-27 (Act) and Natural Health Product Regulations, SOR/2003-196 (NHP Regulations)

Successful party: The Winning Combination Inc.

Date of decision: April 4, 2016  


The Winning Combination Inc. (TWC) marketed a smoking cessation aid in Canada with a confidential active ingredient under the brand name RESOLVE®. Through a series of decisions, Health Canada required that TWC remove RESOLVE from the Canadian marketplace and refused to grant a Product License for RESOLVE under the NHP Regulations.

The Court allowed TWC's application for judicial review, finding that Health Canada's refusal to grant a Product License Application (PLA) for RESOLVE was unjustified. The Court concluded that TWC had been denied procedural fairness and that the PLA and subsequent reconsideration processes were unreasonable and biased. Health Canada's decisions rejecting the PLA were quashed and Health Canada was ordered to grant a licence for RESOLVE within 30 days of the order.


In 2004, the PLA for RESOLVE was submitted to the Natural Health Products Directorate (NHPD). The NHPD initially concluded, based on the authoritative Dictionary of Natural Products (DNP), that RESOLVE met the definition of a natural health product (NHP) under the NHP Regulations. RESOLVE entered the Canadian market in 2006. Later that year, Health Canada revisited its assessment of RESOLVE's PLA in response to allegations of health concerns and non-compliance with certain advertising standards pertaining to the product.

RESOLVE was marketed in Canada as a NHP until July 2007 when the NHPD issued two decisions rejecting TWC's PLA. The first decision, issued in July 2007, rejected TWC's PLA on the basis that there was insufficient evidence to support the safety and efficacy of RESOLVE. The first decision was followed by a public advisory, stop-sale and recall of RESOLVE. The second decision, issued in August 2007, rejected the PLA on a new and separate ground that RESOLVE was not a NHP but should be re-classified as a drug. Consequently, RESOLVE should be subject to the Food and Drug Regulations.

TWC filed for reconsideration of the NHPD's decisions and continuously submitted material to Health Canada between August 2007 and January 2012 in support of its PLA. A final letter was sent to TWC in January 2012 indicating that the PLA was rejected on the basis that the active ingredient in RESOLVE was not a NHP and that there was insufficient evidence to support the efficacy of the product.  

TWC was not afforded procedural fairness

TWC alleged that it was denied procedural fairness in the PLA process, including the notice and the opportunity to be heard before the NHPD's decisions were released. TWC also alleged that the NHPD departed from the usual processes and procedures, resulting in decisions that demonstrated bias, pre-judgement, bad faith and a closed mind. Health Canada asserts that it provided ample opportunity for TWC to be heard.

With respect to both NHPD decisions, the Court found that TWC did not receive notice or the opportunity to address the issues of safety and efficacy, and classification until the decision to reject the PLA was issued. The evidence showed that the reconsideration of the NHPD decisions were "far from impartial or fair [...] information was deliberately withheld from TWC, targets were moved, standards were changed, and despite promises, personnel were involved who had given rise to the problems, thus preventing any true independent assessment." Justice Russell allowed the application for lack of procedural fairness, a reasonable apprehension of bias and unreasonableness.  

TWC satisfied the requirements under the NHP Regulations

TWC argued that it had met the regulatory requirements with respect to the safety, efficacy and classification of RESOLVE as a NHP. TWC submits that the NHPD had no basis to reject the PLA based on efficacy. The standard under the NHP Regulations for supporting efficacy did not require TWC to submit substantive proof as required by the NHPD. With respect to classification, TWC argued that RESOLVE had been classified as a NHP on various occasions prior to the rejection of the PLA. Furthermore, the classification issue was not previously brought to the attention of TWC and was not based on any scientific evidence or testing.

The Court accepted TWC's argument. Justice Russell rejected Health Canada's demand that TWC meet an extremely high standard of conclusive proof in the form of clinical studies to support the efficacy of RESOLVE. With respect to classification, TWC had submitted expert evidence that the active ingredient in RESOLVE is a NHP. The evidentiary record showed that the active ingredient in RESOLVE was still listed as a natural substance in the DNP when the second decision to reject the PLA based on classification as a drug was issued. On these bases, the Court quashed both NHPD decisions rejecting the PLA and all subsequent decisions from reconsiderations.

Health Canada ordered to grant License for RESOLVE

Justice Russell refused to return the matter to Health Canada for reconsideration concluding that the "system did not function as it should have in this case, and there is no evidence that it is likely to if this matter is returned for reconsideration." The Court found no justifiable reason why RESOLVE was kept off the market for 8 years while the PLA and reconsideration process were under review, and as such ordered Health Canada to grant a license for RESOLVE to TWC. The Court awarded solicitor-client costs to TWC on a full indemnity basis.  

Appeal sought

Health Canada has sought appeal of the Court's judgment (Appeal Court File No. A-117-16).

Link to decision:

The Winning Combination Inc. v Canada (Minister of Health), 2016 FC 381

About Norton Rose Fulbright Canada LLP

Norton Rose Fulbright is a global law firm. We provide the world's pre-eminent corporations and financial institutions with a full business law service. We have more than 3800 lawyers and other legal staff based in more than 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.

Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.

Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.

For more information about Norton Rose Fulbright, see

Law around the world

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.